CAPTRUST Financial Advisors’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

CAPTRUST Financial Advisors’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,850	Closed	-$3K	–	4405
2022 Q2	$3K	Sell	1,850 -50	-3%	-$104	﹤0.01%	4379
2022 Q1	$6K	Sell	1,900 -1,000	-34%	-$3.5K	﹤0.01%	4105
2021 Q4	$14K	Hold	2,900	–	–	﹤0.01%	3534
2021 Q3	$22K	Hold	2,900	–	–	﹤0.01%	3104
2021 Q2	$22K	Sell	2,900 -1,900	-40%	-$14.6K	﹤0.01%	3054
2021 Q1	$37K	Buy	4,800 +4,700	+4,700%	+$47K	﹤0.01%	2624
2020 Q4	$1K	Buy	+100	New	+$869	﹤0.01%	3339

Other funds holding SURF

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

AVAI

Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

CAPTRUST Financial Advisors's SURF Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2022, closing a stake of 1,850 shares — an estimated $3K sold.

CAPTRUST Financial Advisors first reported a position in SURF in Q4 2020 and held it in 7 quarters. The position peaked at $37K in Q1 2021. 79 funds tracked by Wall St. Rank hold SURF as of Q3 2022.

CAPTRUST Financial Advisors reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
CAPTRUST Financial Advisors sold 1,850 Surface Oncology, Inc. Common Stock shares in Q3 2022, an estimated $3K.
CAPTRUST Financial Advisors first reported a position in Surface Oncology, Inc. Common Stock in Q4 2020 and held it in 7 quarters.
CAPTRUST Financial Advisors's Surface Oncology, Inc. Common Stock position peaked at $37K in Q1 2021.
79 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.